Aug. 3, 2026 — QT Imaging Holdings, is advancing the direct U.S. commercial strategy for its Breast Acoustic CT Scanner with the appointment of Jason Dyer as Vice President Regional Sales East and Dave Reinhart as Vice President Regional Sales West. Both executives joined QT Imaging in July 2026 and report to Satrajit Misra, the company’s Chief Commercial Officer.
“Building a direct U.S. commercial organization is an important step in QT Imaging’s evolution into a scalable precision imaging platform,” said Misra. “Jason and Dave bring tremendous experience in breast imaging and surgical oncology, established relationships across major healthcare systems, and proven records of introducing innovative medical technologies into complex clinical care environments.
“Working directly with breast imaging centers, clinicians and enterprise health systems will provide a better understanding of their clinical, operational and economic priorities, support evidence generation and physician education, and develop a more direct pathway for adoption of our technology,” he added. “We value our relationship with NXC Imaging and will continue to work collaboratively as we build the internal capabilities to support our next phase of growth.”
These hires support the company’s evolution from a distributor-led sales model toward an integrated commercial model that enhances QT Imaging’s gross margin, direct ownership of customer engagement, strategic account development, clinical education and market development. QT Imaging will continue to work collaboratively with NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA, Inc., under the existing distribution arrangement.
QT Imaging’s commercial team will focus on developing relationships with leading medical centers and clinical stakeholders, assessing customer needs and establishing the infrastructure to support the Company’s longer-term U.S. commercialization strategy. Based on initial success and market feedback, QT Imaging may selectively add further commercial resources in 2027.
By combining the reach and resources of its established distribution relationship with a focused direct commercial organization, QT Imaging aims to strengthen customer relationships, support broader clinical adoption, expand evidence-supported applications, and build a scalable platform for sustainable long-term growth.
Breast Imaging Industry Veterans
Dyer brings two decades of commercial leadership experience across breast imaging, breast cancer diagnostics, surgical oncology and medical devices. Before QT Imaging, he served as Vice President of Sales and Service at Clarix Imaging, where he helped build the company’s initial commercial organization following FDA clearance of its 3D breast specimen CT imaging system and supported significant commercial growth.
Reinhart brings more than 35 years of experience in breast imaging, breast cancer diagnostics, surgical oncology, ultrasound, and medical device commercialization. He has held senior commercial roles at Merit Medical Oncology, Clarix Imaging, SonoCiné, Bioptics/Faxitron and Siemens Medical Systems. Throughout his career, Mr. Reinhart has worked alongside breast radiologists, surgeons and healthcare administrators to introduce innovative technologies across major health systems.
For additional information go to www.qtimaging.com.
August 03, 2026 
